SpeeDx Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 112
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 10

SpeeDx General Information

Description

Developer of a molecular diagnostics test portfolio intended to provide innovative multiplex systems for clinical diagnostics. The company's test portfolio uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance.

Contact Information

Website
www.plexpcr.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • National Innovation Centre
  • Suite G16, Australian Technology Park, 4 Cornwallis Street, Eveleigh
  • Sydney, New South Wales 2015
  • Australia
+61 (02) 0000 0000

SpeeDx Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SpeeDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 0000 Completed Generating Revenue
10. Grant 10-May-2021 00.00 0000 Completed Generating Revenue
9. Later Stage VC (Series B) 11-Feb-2020 0000 0000 00000 Completed Generating Revenue
8. Later Stage VC 05-Aug-2019 0000 0000 Completed Generating Revenue
7. Later Stage VC (Series A) 23-Apr-2019 000 000 Completed Generating Revenue
6. Grant 04-Sep-2017 00.000 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 01-Jul-2016 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
2. Grant 11-May-2014 $1.8M Completed Generating Revenue
To view SpeeDx’s complete valuation and funding history, request access »

SpeeDx Patents

SpeeDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200199651-A1 Nucleic acid ratio determination Pending 21-Dec-2018 000000000
EP-3833778-A1 Multiplex detection of nucleic acids Pending 09-Aug-2018 0000000000
CA-3108430-A1 Multiplex detection of nucleic acids Pending 09-Aug-2018 0000000000
AU-2019316815-A1 Multiplex detection of nucleic acids Pending 09-Aug-2018 0000000000
AU-2018390995-A1 Nucleic acid ratio determination Pending 21-Dec-2017 C12Q1/18
To view SpeeDx’s complete patent history, request access »

SpeeDx Executive Team (6)

Name Title Board Seat Contact Info
Colin Denver Chief Executive Officer
Bhavin Raval Chief Financial Officer
Elisa Mokany Ph.D Co-Founder & Chief Technology Officer
Alison Todd Ph.D Co-Founder & Chief Scientific Officer
Charles Cartwright Vice President of Scientific Affairs
You’re viewing 5 of 6 executive team members. Get the full list »

SpeeDx Board Members (6)

Name Representing Role Since
Adam Wieschhaus Ph.D Northpond Ventures Board Member 000 0000
Andrew Denver Self Chairman 000 0000
Bianca Ogden Platinum Asset Management Board Member 000 0000
John Klopp Self Board Member 000 0000
Michael Rubin MD Northpond Ventures Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

SpeeDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SpeeDx Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CARB-X University Minority 000 0000 000000 0
Illumina Ventures Venture Capital Minority 000 0000 000000 0
Platinum Asset Management Asset Manager Minority 000 0000 000000 0
Northpond Ventures Venture Capital Minority 000 0000 000000 0
Global Connections Fund Other 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »